【24h】

Restless nocturnal eating: A common feature of willis-ekbom syndrome (RLS)

机译:夜间躁动饮食:Willis-ekbom综合征(RLS)的共同特征

获取原文
获取原文并翻译 | 示例
       

摘要

Study Objectives: To determine the frequency of nocturnal eating (NE) and sleep related eating disorder (SRED) in restless legs syndrome (RLS) versus psychophysiological insomnia (INS), and the relationship of these conditions with dopaminergic and sedative-hypnotic medications. Design: Prospective case series. Setting: Sleep disorders center. Patients: Newly diagnosed RLS or INS. Intervention: RLS or INS pharmacotherapy with systematic follow up interview for NE/SRED. Measurements and Results: Patients presenting with RLS (n = 88) or INS (n = 42) were queried for the presence of NE and SRED. RLS patients described nocturnal eating (61%) and SRED (36%) more frequently than INS patients (12% and 0%; both p < 0.0001). These findings were not due to arousal frequency, as INS patients were more likely to have prolonged nightly awakenings (93%) than RLS patients (64%; p = 0.003). Among patients on sedative-hypnotics, amnestic SRED and sleepwalking were more common in the setting of RLS (80%) than INS (8%; p < 0.0001). Further, NE and SRED in RLS were not secondary to dopaminergic therapy, as RLS patients demonstrated a substantial drop (68% to 34%; p = 0.0026) in the frequency of NE after dopamine agents were initiated, and there were no cases of dopaminergic agents inducing novel NE or SRED. Conclusion: NE is common in RLS and not due to frequent nocturnal awakenings or dopaminergic agents. Amnestic SRED occurs predominantly in the setting of RLS mistreatment with sedating agents. In light of previous reports, these findings suggest that nocturnal eating is a non-motor manifestation of RLS with several clinical implications discussed here.
机译:研究目标:确定不安定腿综合征(RLS)与心理生理失眠(INS)的夜间进食(NE)和睡眠相关进食障碍(SRED)的频率,以及这些疾病与多巴胺能和镇静催眠药的关系。设计:预期案例系列。地点:睡眠障碍中心。患者:新诊断的RLS或INS。干预:RLS或INS药物治疗,对NE / SRED进行系统的随访。测量和结果:询问存在RLS(n = 88)或INS(n = 42)的患者是否存在NE和SRED。 RLS患者的夜间进食(61%)和SRED(36%)比INS患者(12%和0%;两者均p <0.0001)更频繁。这些发现不是由于唤醒频率引起的,因为INS患者比RLS患者(64%; p = 0.003)更有可能延长夜间醒来时间(93%)。在使用镇静催眠药的患者中,RLS(80%)的失忆症SRED和梦游比INS(8%; p <0.0001)更常见。此外,RLS中的NE和SRED并非多巴胺能治疗的继发者,因为RLS患者在开始多巴胺药物治疗后出现NE的频率显着下降(68%至34%; p = 0.0026),而且没有多巴胺能治疗的病例。诱导新型NE或SRED的药物。结论:NE在RLS中很常见,而不是由于频繁的夜间觉醒或多巴胺能药物。遗忘性SRED主要发生在用镇静剂对RLS进行误治疗的情况下。根据以前的报道,这些发现表明,夜间进食是RLS的非运动表现,在这里讨论了一些临床意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号